HAPILTO Trademark

Trademark Overview

On Tuesday, March 23, 2021, a trademark application was filed for HAPILTO with the United States Patent and Trademark Office. The USPTO has given the HAPILTO trademark a serial number of 90596689. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 2, 2024. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The HAPILTO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, metabolic, hematological, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, and viral diseases and disorders; Pharmaceutical preparations for the treatment of pain
hapilto

General Information

Serial Number90596689
Word MarkHAPILTO
Filing DateTuesday, March 23, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 31, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, metabolic, hematological, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, and viral diseases and disorders; Pharmaceutical preparations for the treatment of pain

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, June 27, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events

Event DateEvent Description
Friday, March 26, 2021NEW APPLICATION ENTERED
Sunday, June 27, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 23, 2021ASSIGNED TO EXAMINER
Friday, July 23, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 11, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 31, 2021PUBLISHED FOR OPPOSITION
Tuesday, August 31, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 26, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 26, 2022SOU EXTENSION 1 FILED
Monday, May 30, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, May 31, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Wednesday, June 1, 2022PETITION TO REVIVE-GRANTED
Wednesday, June 1, 2022SOU EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, June 1, 2022TEAS PETITION TO REVIVE RECEIVED
Wednesday, June 1, 2022NOTICE OF REVIVAL - E-MAILED
Monday, July 11, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 12, 2022SOU EXTENSION 1 GRANTED
Wednesday, July 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 26, 2022SOU EXTENSION 2 FILED
Monday, November 28, 2022ABANDONMENT - NO USE STATEMENT FILED
Monday, November 28, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, November 29, 2022PETITION TO REVIVE-GRANTED
Tuesday, November 29, 2022TEAS PETITION TO REVIVE RECEIVED
Tuesday, November 29, 2022SOU EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, November 29, 2022NOTICE OF REVIVAL - E-MAILED
Friday, December 2, 2022SOU EXTENSION 2 GRANTED
Saturday, December 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 31, 2023SOU TEAS EXTENSION RECEIVED
Friday, March 31, 2023SOU EXTENSION 3 FILED
Friday, March 31, 2023SOU EXTENSION 3 GRANTED
Tuesday, April 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 10, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, October 10, 2023SOU EXTENSION 4 FILED
Tuesday, October 10, 2023SOU EXTENSION 4 GRANTED
Thursday, October 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 8, 2024SOU EXTENSION 5 GRANTED
Monday, April 8, 2024SOU TEAS EXTENSION RECEIVED
Monday, April 8, 2024SOU EXTENSION 5 FILED
Tuesday, April 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 2, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, December 2, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

hapilto pharmaceutical treatment preparations hepatological nephrological infectious allergic autoimmune respiratory disorders